• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Down0.63%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    9.41 Down 0.65(6.46%) Apr 27, 4:00PM EDT
    |After Hours : 9.46 Up 0.05 (0.54%) Apr 27, 7:59PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development16,426  12,070  12,177  12,842  
    Selling General and Administrative5,235  3,694  3,589  3,393  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (21,661) (15,764) (15,766) (16,235)
    Income from Continuing Operations
    Total Other Income/Expenses Net79  101  117  158  
    Earnings Before Interest And Taxes(21,582)(15,663)(15,649)(16,077)
    Interest Expense14  4  8  11  
    Income Before Tax(21,596)(15,667)(15,657)(16,088)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,596)(15,667)(15,657)(16,088)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,596) (15,667) (15,657) (16,088)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,596) (15,667) (15,657) (16,088)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.